Lactose Intolerance: Clinical Trials

2 trials for Lactose Intolerance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow Lactose Intolerance: new trials by email Literature Review of Lactose Intolerance trials Research Report on Lactose Intolerance

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance
RP-G28, Placebo - Lactose Intolerance
Phase 2 / Phase 3CompletedRitter Pharmaceuticals, Inc.3772016-02-012018-04-04
Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance
RP-G28 or placebo - Lactose Intolerance
Phase 2CompletedRitter Pharmaceuticals, Inc.612011-04-012011-12-08

Broader conditions

Carbohydrate Metabolism, Inborn Errors (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Intestinal Diseases (2)  ·  Malabsorption Syndromes (2)  ·  Metabolic Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Nutritional and Metabolic Diseases (2)

Interventions

RP-G28 (2)

Sponsors

Ritter Pharmaceuticals, Inc. (2)

Countries

United States (2)

Results publications

PMID 24330605, PMID 34365905